Mar 30, 2026 09:25AM
Jul 31, 2025 03:14PM
Oct 31, 2024 03:13AM
May 22, 2024 09:25AM
Nov 6, 2023 08:01AM
Feb 13, 2023 07:34AM
Jan 9, 2023 07:03AM Biogen (BIIB) gains as analysts reflect positively on Leqembi's approval, pricing
Nov 30, 2022 08:52AM
Nov 28, 2022 08:51AM
Oct 25, 2022 09:02AM
Sep 28, 2022 08:27AM
Jun 22, 2022 07:01AM
Jan 12, 2022 09:29AM
Jan 11, 2022 07:08AM Morgan Stanley Sees 90% Probability of Biogen (BIIB) Moving 10%+ Higher Upon Receiving Alzheimer's Disease NCD Draft Coverage
Aug 30, 2021 07:11AM
Aug 17, 2021 07:43AM
Jun 8, 2021 03:17AM
Jun 7, 2021 09:30AM
Mar 26, 2021 07:23AM
Mar 19, 2021 08:18AM
Jan 19, 2021 02:34AM Biogen (BIIB) PT Lowered to $352 at Morgan Stanley
Jul 27, 2020 09:30AM
Jul 27, 2020 05:02AM
Jul 15, 2020 07:51AM
May 28, 2020 06:49AM
May 4, 2020 08:02PM
Apr 22, 2020 09:05AM
Feb 18, 2020 09:30AM Pre-Open Stock Movers 02/18: (LM) (BEN) (AAP) Higher; (FLR) (CAG) (CVU) Lower (more...)
Oct 23, 2019 07:11AM
Jan 30, 2019 06:12AM
Jan 3, 2019 07:06AM
Oct 24, 2018 06:59AM
Jul 25, 2018 07:46AM
Jul 13, 2018 09:30AM
Apr 25, 2018 07:24AM Biogen (BIIB) PT Raised to $369 at Morgan Stanley
Apr 13, 2018 07:31AM
Nov 14, 2017 11:31AM
Oct 5, 2017 05:39AM
Sep 6, 2017 04:01PM
Aug 14, 2017 05:43PM
Jul 26, 2017 07:58AM
Jul 10, 2017 09:08AM Biogen (BIIB) PT Lowered to $301 at Morgan Stanley
Jun 14, 2017 09:42AM
May 15, 2017 03:23PM
May 15, 2017 11:01AM
Mar 16, 2017 09:34AM
Mar 16, 2017 07:56AM
Mar 16, 2017 06:49AM
Mar 16, 2017 02:55AM Morgan Stanley Downgrades Biogen (BIIB) to Equalweight
Feb 14, 2017 05:23PM

224,861 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All